South Dakota legislation · 2025 Regular Session
South Dakota SB154: Prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.
Status: Passed both chambers, March 13, 2025
What the bill says
An Act ENTITLED An Act to prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.
From the enrolled text:
An Act ENTITLED An Act to prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor. Be it enacted by the Legislature of the State of South Dakota: Section 1. That § 37-24-6 be AMENDED: 37-24-6. It is a deceptive act or practice for any person to: (1) Knowingly act, use, or employ any deceptive act or practice, fraud, false pretense, false promises, or misrepresentation or to conceal, suppress, or omit any material fact in connection with the sale or advertisement of any merchandise or the solicitation of contributions for charitable purposes, regardless of whether any person has in fact been misled, deceived, or damaged thereby; (2) Advertise price reductions without satisfying one of the following: (a) Including in the advertisement the specific basis for the claim of a price reduction; or (b) Offering the merchandise for sale at the higher price from which the reduction is taken for at least seven consecutive business days during the sixty-day period prior to the advertisement. Any person advertising consumer property or services in this state, which advertisements contain representations or statements as to any type of savings claim, including reduced price claims and price comparison value claims, shall maintain reasonable records for a period of two years from the date of sale and advertisement, …
Sponsors
- Tim Reed (R, HD-007) · primary sponsor
- Taylor Rehfeldt (R, HD-014) · primary sponsor
- Eric Emery (D, HD-026)
- Scott Moore (R, HD-023)
- Erik Muckey (D, HD-015)
- Carl Perry (R, SD-003)
- Matt Roby (R, HD-005)
- Stephanie Sauder (R, SD-004)
- Jamie Smith (D, SD-015)
- Glen Vilhauer (R, SD-005)
- Kadyn Wittman (D, HD-015)
Votes
- Do Pass Amended (March 5, 2025): 65 yea, 5 nay, passed
- Do Pass (March 4, 2025): 8 yea, 5 nay, passed
- Do Pass Amended (February 21, 2025): 30 yea, 3 nay, passed
- Do Pass Amended (February 19, 2025): 6 yea, 1 nay, passed
Common questions
- What is SB154?
- SB154 is a bill in the South Dakota Legislature (2025 Regular Session): Prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.
- What does SB154 do?
- In its own words: An Act ENTITLED An Act to prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.
- What is the status of SB154?
- Passed both chambers as of March 13, 2025.
- Who sponsored SB154?
- Tim Reed (R, HD-007), with 10 co-sponsors.
- Where is the official record for SB154?
- On the South Dakota Legislature website: https://sdlegislature.gov/#/Session/Bill/25981
Source: official South Dakota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.